Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment

Cutaneous and Ocular Toxicology

Volumn 31, Issue 2, 2012, Pages 144-147

  Lee, Won June ^a   Ko, Myung Kyoo ^a   Lee, Byung Ro ^a  

^a Hanyang University   (South Korea)

Author keywords

hydorxychloroquine retinopathy; Hydroxychloroquine; pigment epithelium detachment; spectral domain optical coherence tomography

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; AUTOFLUORESCENCE IMAGING; CASE REPORT; CORNEA OPACITY; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTERNIST; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; RETINA DETACHMENT; RETINA FOVEA; RETINOPATHY; REVIEW; SCOTOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL DISORDER;

ADULT; ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; HYDROXYCHLOROQUINE; RETINAL DETACHMENT; RETINAL DISEASES;

EID: 84862060502     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2011.627076     Document Type: Review

References (16)

1. Tehrani R, Ostrowski RA, Hariman R, Jay WM. Ocular toxicity of hydroxychloroquine. Semin Ophthalmol 2008;23:201-209.
2. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997;40:1482-1486.
3. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 2003;110:1321-1326.
4. Bonanomi MT, Dantas NC, Medeiros FA. Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Experiment Ophthalmol 2006;34:130-136.
5. Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign). Clin Ophthalmol 2010;4:1151-1158.
6. Kellner U, Renner AB, Tillack H. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/ hydroxychloroquine. Invest Ophthalmol Vis Sci 2006;47:3531-3538.
7. Kelmenson AT, Brar VS, Murthy RK, Chalam KV. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy. Eur J Ophthalmol 2010;20:785-788.
8. Korah S, Kuriakose T. Optical coherence tomography in a patient with chloroquine-induced maculopathy. Indian J Ophthalmol 2008;56:511-513.
9. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011;118:415-422.
10. Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 2007;125:775-780.
11. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978;17:1158-1175.
12. Yam JC, Kwok AK. Ocular toxicity of hydroxychloroquine. Hong Kong Med J 2006;12:294-304.
13. Afshari FT, Fawcett JW. Improving RPE adhesion to Bruch's membrane. Eye (Lond) 2009;23:1890-1893.
14. Ritter M, Bolz M, Sacu S, Deák GG, Kiss C, Pruente C et al. Effect of intravitreal ranibizumab in avascular pigment epithelial detachment. Eye (Lond) 2010;24:962-968.
15. Sahu DK, Namperumalsamy P, Hilton GF, de Sousa NF. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2000;84:485-492.
16. Wasmuth S. Pathogenetic concepts for pigment epithelial detachment in exudative AMD. Ophthalmologe 2010;107:1109-1114.